Brief: Xspray Q3 Revenue SEK 0

Xspray Pharma publ AB

06/11/2024 07:00

Nov 06 (Reuters) - Xspray Q3 adjusted EPS SEK -2.44.
* Q3 adjusted free cash flow SEK -41.275 million
* Q3 pretax profit SEK -82.272 million